Beijing Hospital
196
22
27
42
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
3.6%
7 terminated/withdrawn out of 196 trials
85.7%
-0.8% vs industry average
17%
33 trials in Phase 3/4
0%
0 of 42 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (196)
Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients With Diabetes
Role: collaborator
ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC
Role: lead
Mini-dose Dexmedetomidine-Esketamine Infusion and Perioperative Sleep Quality
Role: collaborator
SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak
Role: collaborator
Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer
Role: collaborator
Adaptive Blood Purification for the Treatment of Patients With Septic Shock
Role: collaborator
ATRA for Management of Primary ITP
Role: collaborator
Anesthesia and Non-small Cell Lung Cancer Recurrence
Role: collaborator
Screening and Management of Adults With Asthma and Allergic Diseases
Role: lead
A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)
Role: collaborator
PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis
Role: collaborator
Multimodal Neurofunctional Profiling in Stroke
Role: collaborator
Metabolic Characteristics and Prognostic Model of Acute Coronary Syndrome Complicated With Obstructive Sleep Apnea
Role: lead
Electroacupuncture Treatment for Discogenic Low Back Pain
Role: lead
A Novel 532-nm Picosecond Laser for Freckle Treatment in Chinese Patients
Role: lead
Comprehensive Care of Sleep Disordered Breathing
Role: collaborator
Isa-VRD in TIE HRMM
Role: collaborator
Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients
Role: collaborator
External Validation of Ischemia and Hemorrhage Risk Models in Patients With Coronary Heart Disease
Role: lead
Study of Roxadustat for Reducing the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting
Role: collaborator